{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:37:39Z","timestamp":1793911059082,"version":"4.8.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":22,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["314061271-TRR\/CRC 205-1\/2"],"award-info":[{"award-number":["314061271-TRR\/CRC 205-1\/2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007952","name":"Eva Luise und Horst K\u00f6hler Foundation for People with Rare Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007952","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner Fresenius Foundation","doi-asserted-by":"publisher","award":["2022_EKFKSE.03"],"award-info":[{"award-number":["2022_EKFKSE.03"]}],"id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.eprac.2026.09.010","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:23:04Z","timestamp":1790263384000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Adverse events During the Diagnostic Workup for Primary Aldosteronism"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-8560-9920","authenticated-orcid":false,"given":"Sybille","family":"Fuld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgiana","family":"Constantinescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Pamporaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmina T.","family":"Fuss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Hahner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Yagoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Trosbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques W.M.","family":"Lenders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme","family":"Eisenhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.eprac.2026.09.010_bib1","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/cen.15296","article-title":"Prevalence of primary aldosteronism among patients with hypertension","volume":"103","author":"Goyal","year":"2025","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"10.1016\/j.eprac.2026.09.010_bib2","doi-asserted-by":"crossref","first-page":"408","DOI":"10.5694\/mja2.51438","article-title":"Detecting primary aldosteronism in Australian primary care: a prospective study","volume":"216","author":"Libianto","year":"2022","journal-title":"Med J Aust"},{"issue":"1","key":"10.1016\/j.eprac.2026.09.010_bib3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","article-title":"Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis","volume":"6","author":"Monticone","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"10.1016\/j.eprac.2026.09.010_bib4","doi-asserted-by":"crossref","DOI":"10.1111\/jch.70128","article-title":"Primary aldosteronism and long-term cardiovascular complications: comparison of medical versus surgical treatment","volume":"27","author":"Benameur","year":"2025","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"9","key":"10.1016\/j.eprac.2026.09.010_bib5","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1210\/clinem\/dgaf284","article-title":"Primary aldosteronism: an endocrine society clinical practice guideline","volume":"10","author":"Adler","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"38","key":"10.1016\/j.eprac.2026.09.010_bib6","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC guidelines for the management of elevated blood pressure and hypertension","volume":"45","author":"McEvoy","year":"2024","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.eprac.2026.09.010_bib7","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1097\/HJH.0000000000001088","article-title":"Guidelines for primary aldosteronism: uptake by primary care physicians in Europe","volume":"34","author":"Mulatero","year":"2016","journal-title":"J Hypertens"},{"issue":"3","key":"10.1016\/j.eprac.2026.09.010_bib8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.7326\/M20-4873","article-title":"Testing for primary aldosteronism and mineralocorticoid receptor antagonist use among U.S. veterans : a retrospective cohort study","volume":"174","author":"Cohen","year":"2021","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.eprac.2026.09.010_bib9","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1161\/HYPERTENSIONAHA.123.21965","article-title":"Diagnostic delay and disease burden in primary aldosteronism: an international patient survey","volume":"81","author":"Ananda","year":"2024","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.eprac.2026.09.010_bib10","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1007\/s40620-022-01267-3","article-title":"Screening for primary aldosteronism is underutilised in patients with chronic kidney disease","volume":"35","author":"Chauhan","year":"2022","journal-title":"J Nephrol"},{"issue":"5","key":"10.1016\/j.eprac.2026.09.010_bib11","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.eprac.2026.09.010_bib12","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1530\/EJE-11-0914","article-title":"Confirmatory testing in primary aldosteronism: extensive medication switching is not needed in all patients","volume":"166","author":"Solar","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.eprac.2026.09.010_bib13","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1530\/EJE-19-0138","article-title":"Safety of medical adjustment and confirmatory testing in the diagnostic work-up of primary aldosteronism","volume":"181","author":"Heinrich","year":"2019","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.eprac.2026.09.010_bib14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11154-011-9163-7","article-title":"Commentary on the endocrine society practice guidelines: consequences of adjustment of antihypertensive medication in screening of primary aldosteronism","volume":"12","author":"Fischer","year":"2011","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.eprac.2026.09.010_bib15","unstructured":"Mourougavelou V, Qamar S, Akker S, et al. The saline infusion test, but not the captopril challenge test, is associated with intra-test hypertension and hypokalaemia in patients being investigated for primary aldosteronism 77. Edinburgh, UK: Endocrine Abstracts:4. 10.1530\/endoabs.77.P4"},{"issue":"2","key":"10.1016\/j.eprac.2026.09.010_bib16","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1161\/HYPERTENSIONAHA.107.091827","article-title":"Comparison of the captopril and the saline infusion test for excluding aldosterone-producing adenoma","volume":"50","author":"Rossi","year":"2007","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.eprac.2026.09.010_bib17","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/j.tvir.2010.02.006","article-title":"Adrenal vein sampling","volume":"13","author":"Kahn","year":"2010","journal-title":"Tech Vasc Interv Radiol"},{"issue":"3","key":"10.1016\/j.eprac.2026.09.010_bib18","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1210\/jcem.86.3.7287","article-title":"Identification of the etiology of primary aldosteronism with adrenal vein sampling in patients with equivocal computed tomography and magnetic resonance findings: results in 104 consecutive cases","volume":"86","author":"Rossi","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.eprac.2026.09.010_bib19","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1161\/HYPERTENSIONAHA.124.23029","article-title":"Steroidomics-based screening for primary aldosteronism: impact of antihypertensive drugs","volume":"81","author":"Constantinescu","year":"2024","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.eprac.2026.09.010_bib20","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1093\/jalm\/jfae017","article-title":"Screening for primary aldosteronism by mass spectrometry versus immunoassay measurements of aldosterone: a prospective within-patient study","volume":"9","author":"Fuld","year":"2024","journal-title":"J Appl Lab Med"},{"issue":"10","key":"10.1016\/j.eprac.2026.09.010_bib21","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1097\/HJH.0000000000004098","article-title":"The saline infusion test with mass spectrometric measurements of aldosterone to confirm primary aldosteronism","volume":"43","author":"Pamporaki","year":"2025","journal-title":"J Hypertens"},{"key":"10.1016\/j.eprac.2026.09.010_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2024.05.033","article-title":"2024 European society of hypertension clinical practice guidelines for the management of arterial hypertension","volume":"126","author":"Kreutz","year":"2024","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.eprac.2026.09.010_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"issue":"2","key":"10.1016\/j.eprac.2026.09.010_bib24","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"issue":"2","key":"10.1016\/j.eprac.2026.09.010_bib25","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/HJH.0000000000000447","article-title":"Effects of blood pressure lowering on outcome incidence in hypertension: 4. Effects of various classes of antihypertensive drugs\u2014overview and meta-analyses","volume":"33","author":"Thomopoulos","year":"2015","journal-title":"J Hypertens"},{"issue":"15","key":"10.1016\/j.eprac.2026.09.010_bib26","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1001\/jama.283.15.1967","article-title":"Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)","volume":"283","year":"2000","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.eprac.2026.09.010_bib27","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/sj.pcan.4500211","article-title":"Doxazosin in the treatment of benign prostatic hyperplasia. A review of the safety profile in older patients","volume":"1","author":"Kirby","year":"1997","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"7","key":"10.1016\/j.eprac.2026.09.010_bib28","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1097\/HJH.0b013e3283472643","article-title":"Peripheral edema associated with calcium channel blockers: incidence and withdrawal rate--a meta-analysis of randomized trials","volume":"29","author":"Makani","year":"2011","journal-title":"J Hypertens"},{"issue":"Suppl 1","key":"10.1016\/j.eprac.2026.09.010_bib29","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1148\/rg.25si055514","article-title":"Adrenal vein sampling: how to make it quick, easy, and successful","volume":"25","author":"Daunt","year":"2005","journal-title":"Radiographics"},{"issue":"6","key":"10.1016\/j.eprac.2026.09.010_bib30","doi-asserted-by":"crossref","first-page":"891","DOI":"10.7326\/0003-4819-76-6-391","article-title":"Preoperative lateralisation of aldosterone-producing tumours in primary aldosteronism","volume":"76","author":"Scoggins","year":"1972","journal-title":"Ann Int Med"},{"issue":"2","key":"10.1016\/j.eprac.2026.09.010_bib31","first-page":"223","article-title":"Psychosocial factors and hypertension: a review of the literature","volume":"35","author":"Cuevas","year":"2017","journal-title":"Cardiol Clin"},{"issue":"2","key":"10.1016\/j.eprac.2026.09.010_bib32","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1007\/s12020-024-03798-0","article-title":"Feasibility of primary aldosteronism diagnosis in initial evaluation without medication withdrawal or confirmatory tests","volume":"85","author":"Ruiz-Sanchez","year":"2024","journal-title":"Endocrine"},{"issue":"1","key":"10.1016\/j.eprac.2026.09.010_bib33","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s12020-023-03520-6","article-title":"Screening for primary aldosteronism on and off interfering medications","volume":"83","author":"Li","year":"2024","journal-title":"Endocrine"},{"issue":"2","key":"10.1016\/j.eprac.2026.09.010_bib34","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1161\/HYPERTENSIONAHA.123.21983","article-title":"Long-term follow-up of patients with elevated aldosterone-to-renin ratio but negative confirmatory test: the progression of primary aldosteronism phenotypes","volume":"81","author":"Buffolo","year":"2024","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.eprac.2026.09.010_bib35","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1046\/j.1365-2265.2002.01613.x","article-title":"Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism","volume":"57","author":"Seifarth","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"10.1016\/j.eprac.2026.09.010_bib36","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1161\/01.HYP.0000038478.59760.41","article-title":"Drug effects on aldosterone\/plasma renin activity ratio in primary aldosteronism","volume":"40","author":"Mulatero","year":"2002","journal-title":"Hypertension"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X26011523?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X26011523?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:13:21Z","timestamp":1793909601000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X26011523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":36,"alternative-id":["S1530891X26011523"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2026.09.010","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adverse events During the Diagnostic Workup for Primary Aldosteronism","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2026.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 AACE. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}